Atlas Trials

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

Clinical trial NCT01614197 · COMPLETED

Trial details

NCT number
NCT01614197
Sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma
Start date
2015-07-03
Primary completion
2019-12-15
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.